European Archives - Page 1009 of 1363 - European Medical Journal

Novel Genomic Scoring System Could Revolutionise Coronary Artery Disease Stratification

An innovative genomic scoring system, metaGRS, is proving effective at stratifying coronary artery disease (CAD) patients, according to results from a…

Improving on the Mediterranean Diet: The Benefits of Seed Oils

Replacing food rich in saturated fats, such as butter or lard, with those rich in unsaturated fats, such as olive oil, has long been known to reduce…

European Medical Journal Presents: EMJ Respiratory 6.1

The European Medical Journal has published the latest edition of the EMJ Respiratory eJournal, which includes a comprehensive review…

Assessment of Efficacy of Omalizumab Retreatment in Patients With Severe Asthma

Omalizumab is a recombinant humanised monoclonal anti-IgE antibody currently approved in the USA and Europe for treating inadequately controlled allergic…

Focussing on The Patient: Future Prospects in Alpha 1 Management

With new patient-centric and scientific networks being created, Prof Chorostowska-Wynimko explored how these initiatives, such as the European Alpha-1…

Review of the 28th European Respiratory Society International Congress 2018

The ‘City of Peace’, Paris, France, played host to this year’s European Respiratory Society (ERS) International Congress. With the nation bringing forth…

EMJ Respiratory 6.1 2018

The 2018 edition of this eJournal presents key research, discussions, and future directions for the field of respiratory medicine.

Polymetallic Dust-Induced Pneumoconiosis: An Experimental Study

Dust load and oxidative stress play a leading role in the development of pneumoconiosis. The aim of this study was to examine the role of macrophages and…

Back to Basics in Asthma and COPD: Optimising the Patient Journey

The objective of this symposium was to build on the guiding principles of asthma and chronic obstructive pulmonary disease (COPD) and to address some…

Daily Physical Activity in Patients with Severe Eosinophilic Asthma and the Effect of Anti-IL-5 Therapy

Severe asthma, with an estimated prevalence of 5–10% in the total asthma population, impacts considerably on morbidity, mortality, and socioeconomic cost…